1. Circulating cell-free DNA sequencing for early detection of lung cancer;Xue;Expert. Rev. Mol. Diagn.,2023
2. Patients’ perceptions at diagnosis: lung cancer discovery and provider relationships;Somayaji;Cancer Nurs.,2022
3. Serum carcinoembryonic antigen elevation in benign lung diseases;Yang;Sci. Rep.,2021
4. The diagnostic value of the combination of carcinoembryonic antigen, squamous cell carcinoma-related antigen, CYFRA 21-1, neuron-specific enolase, tissue polypeptide antigen, and progastrin-releasing peptide in small cell lung cancer discrimination;Chen;Int. J. Biol. Markers,2021
5. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients;Dal Bello;J. Transl. Med.,2019